mellowyellow
Well-known Member
Reuters / Wednesday, February 24, 2021
Felicisima de la Fuente, a 106-year-old resident, watches a special theatre show for residents and nursing home workers who have achieved immunity against the coronavirus after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24. REUTERS/Sergio Perez
Felicisima de la Fuente, a 106-year-old resident, watches a special theatre show for residents and nursing home workers who have achieved immunity against the coronavirus after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24. REUTERS/Sergio Perez